BioNTech SE (BNTX)

NASDAQ
Currency in USD
Disclaimer
100.62
-2.81(-2.72%)
Real-time Data
Day's Range
99.94101.98
52 wk Range
88.00188.99
Prev. Close
103.43
Open
101.87
Day's Range
99.94-101.98
52 wk Range
88-188.99
Volume
599,340
Average Volume (3m)
653,992
1-Year Change
-39.27%
Shares Outstanding
237,715,500
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
123.95
Upside +23.19%

People Also Watch

24.14
DOCS
-1.51%
14.80
VALE
+0.82%
103.92
MRK
+0.16%
32.28
SPHR
-1.15%
847.93
REGN
+0.93%
How do you feel today about BNTX?
Vote to see community's results!
or

BioNTech SE Company Profile

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.